-
Artefan Tablets 20/120 mg 24's
KSh 55.00
-
Alerid Syrup 30ml
KSh 90.00
Empiget 25mg Tablet 14`s
KSh 1,750.00
Empiget 25mg Tablet contains Empagliflozin, which is an antidiabetic drug used to control blood sugar in type 2 diabetes patients. It is classified as an SGLT2 inhibitor, helping to eliminate extra glucose via urine and enhancing blood sugar regulation.
Anti-Diabetics
Suggested Use
- Management of blood sugar levels in adults with type 2 diabetes mellitus, particularly for patients whose blood sugar levels are not adequately controlled by diet, exercise, and other medications.
- May also help reduce the risk of cardiovascular complications in patients with both type 2 diabetes and established cardiovascular disease.
Dosage:
- Adults: The usual dose is one Empiget 25mg tablet taken once daily, typically in the morning, with or without food.
- Adjustment: Always follow the dose prescribed by a healthcare professional, as they may adjust it based on individual patient needs and responses.
Warning
- While SGLT2 inhibitors alone may not cause hypoglycemia, the risk can increase if used with other antidiabetic medications (e.g., insulin or sulfonylureas).
- Periodic kidney function tests are recommended, as Empagliflozin can affect kidney function.
- This medication may increase urination, leading to dehydration or an electrolyte imbalance. It is essential to stay hydrated.
- Rarely, it may cause ketoacidosis. Seek immediate medical help if symptoms like nausea, vomiting, abdominal pain, or unusual tiredness occur.
- There is an increased risk of urinary tract and genital infections with Empagliflozin. Notify a healthcare provider if signs of infection appear.
- Not recommended for use during pregnancy or breastfeeding due to potential risks to the fetus or infant.
- Do not use if allergic to Empagliflozin or any other ingredient in the medication.
